EFFICACY AND SAFETY OF EMAPALUMAB, A FULLY HUMAN, ANTI-INTERFERON GAMMA MONOCLONAL ANTIBODY, DESCRIBED IN TREATMENT-NAIVE PATIENTS WITH PRIMARY HEMOPHAGOCYTIC LYMPHOHISTOCYTOSIS

被引：0

作者：

Locatelli, Franco ^{[1
,2
]}

Jordan, Michael ^{[3
,4
,5
]}

Allen, Carl ^{[6
]}

Cesaro, Simone ^{[7
]}

Rizzari, Carmelo ^{[8
]}

Rao, Anupama ^{[9
]}

Degar, Barbara ^{[10
]}

Garrington, Timothy ^{[11
]}

Sevilla, Julian ^{[12
,13
]}

Putti, Maria Caterina ^{[14
]}

Fagioli, Franca ^{[15
]}

Ahlmann, Martina ^{[16
]}

Dapena Diaz, Jose-Luis ^{[17
]}

Henry, Michael ^{[18
]}

De Benedetti, Fabrizio ^{[19
]}

Grom, Alexei ^{[20
]}

Jacqmin, Philippe ^{[21
]}

Ballabio, Maria ^{[22
]}

de Min, Cristina ^{[23
]}

机构：

[1] Sapienza Univ Rome, Dept Pediat, Rome, Italy

[2] IRCCS Bambino Gesu Childrens Hosp, Dept Pediat Hematol Oncol, Rome, Italy

[3] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Immunobiol, Cincinnati, OH 45229 USA

[4] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA

[5] Univ Cincinnati, Coll Med, Cincinnati, OH USA

[6] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA

[7] Azienda Osped Univ Integrata, Woman & Child Hosp, Pediat Hematol Oncol, Verona, Italy

[8] Univ Milano Bicocca, Pediat Hematol Oncol Unit, Monza Brianza Bambino Mamma Fdn, Monza, Italy

[9] Great Ormond St Hosp Sick Children, Dept Hematol, London, England

[10] Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat Hematol Oncol, Boston, MA USA

[11] Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Aurora, CO USA

[12] Fdn Invest Biomed Hosp Infantil Univ Nino Jesus, Ctr Invest Biomed Red Enfermedades Raras, Dept Pediat Hematol Oncol, Madrid, Spain

[13] Fdn Invest Biomed Hosp Infantil Univ Nino Jesus, Ctr Invest Biomed Red Enfermedades Raras, Dept Hematol & Oncol, Madrid, Spain

[14] Univ Hosp Padova, Clin Pediat Hematol Oncol, Padua, Italy

[15] Regina Margherita Hosp, Div Pediat Oncohematol, Turin, Italy

[16] Univ Childrens Hosp, Dept Pediat Hematol & Oncol, Munster, Germany

[17] Hosp Univ Vall dHebron, Dept Pediat Hematol & Oncol, Barcelona, Spain

[18] Phoenix Childrens Hosp, Ctr Canc & Blood Disorders, Phoenix, AZ USA

[19] IRCCS Bambino Gesu Childrens Hosp, Div Rheumatol, Rome, Italy

[20] Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Cincinnati, OH 45229 USA

[21] MnS Modelling & Simulat, Dinant, Belgium

[22] Swedish Orphan BiovitrumAG Sobi, Basel, Switzerland

[23] Swedish Orphan Biovitrum AG Sobi, Basel, Switzerland

来源：

PEDIATRIC BLOOD & CANCER | 2021年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2

共 50 条

[1] Population Pharmacokinetic Analysis of Emapalumab, a Fully Human, Anti-Interferon Gamma Monoclonal Antibody, in Children with Primary Hemophagocytic Lymphohistiocytosis
Laveille, Christian
Jacqmin, Philippe
de Graaf, Kathy
de Min, Cristina
BLOOD, 2020, 136
[2] POPULATION PHARMACOKINETIC (PK) ANALYSIS OF EMAPALUMAB, A FULLY HUMAN, ANTI-INTERFERON GAMMA (IFNγ) MONOCLONAL ANTIBODY, IN PATIENTS WITH PRIMARY HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH)
Laveille, Christian
Jacqmin, Philippe
de Graaf, Kathy
de Min, Cristina
PEDIATRIC BLOOD & CANCER, 2021, 68
[3] Emapalumab, a Fully Human Anti-Interferon Gamma Monoclonal Antibody, in Pediatric Patients with Primary Hemophagocytic Lymphohistiocytosis: Long-Term Follow-up of a Phase 2/3 Study
Jordan, Michael B.
Allen, Carl
Rao, Anupama
Rizzari, Carmelo
Cesaro, Simone
Putti, Maria Caterina
Sevilla, Julian
de Min, Cristina
Ballabio, Maria
Asnaghi, Veronica
Stoltenberg, Anna
Kanceva, Radmila
Locatelli, Franco
BLOOD, 2023, 142
[4] OVERALL RESPONSE RATE (ORR) WITH EMAPALUMAB, A FULLY HUMAN, ANTI-INTERFERON GAMMA MONOCLONAL ANTIBODY, IN PATIENTS WITH PRIMARY HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH): RESULTS OF A SENSITIVITY ANALYSIS
Locatelli, Franco
Jordan, Michael
Allen, Carl
Cesaro, Simone
Rizzari, Carmelo
Rao, Anupama
Degar, Barbara
Garrington, Timothy
Sevilla, Julian
Putti, Maria Caterina
Fagioli, Franca
Ahlmann, Martina
Dapena Diaz, Jose-Luis
Henry, Michael
De Benedetti, Fabrizio
Grom, Alexei
Jacqmin, Philippe
Ballabio, Maria
Stoltenberg, Anna
Vagero, Marten
de Min, Cristina
PEDIATRIC BLOOD & CANCER, 2021, 68
[5] Emapalumab, an Anti-Interferon Gamma Monoclonal Antibody in Two Patients with NLRC4-Related Disease and Severe Hemophagocytic Lymphohistiocytosis (HLH)
Bracaglia, Claudia
Prencipe, Giusi
Insalaco, Antonella
Caiello, Ivan
Marucci, Giulia
Pecoraro, Raffaele
Pardeo, Manuela
Dolezalova, Pavla
Fingerhutova, Sarka
Ballabio, Maria
de Min, Cristina
De Benedetti, Fabrizio
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[6] A NOVEL TARGETED APPROACH TO THE TREATMENT OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH) WITH NI-0501, AN ANTI-INTERFERON GAMMA MONOCLONAL ANTIBODY
Jordan, Michael B.
Locatelli, Franco
Allen, Carl
De Benedetti, Fabrizio
Grom, Alexei
Ballabio, Maria
Ferlin, Walter
De Min, Cristina
JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (03) : 282 - 282
[7] Macrophage Activation Syndrome (MAS) in Systemic Juvenile Idiopathic Arthritis (sJIA): Treatment with Emapalumab, an Anti-Interferon Gamma (IFNγ) Monoclonal Antibody
De Benedetti, Fabrizio
Grom, Alexei A.
Brogan, Paul
Bracaglia, Claudia
Pardeo, Manuela
Marucci, Giulia
Eleftheriou, Despina
Papadopoulou, Charalampia
Quartier, Pierre
Anton, Jordi
Frederiksen, Rikke
Asnaghi, Veronica
Ballabio, Mari
Min, Cristinade
BLOOD, 2021, 138
[8] Structural Insights into the Neutralization Properties of the Fully Human, Anti-interferon Monoclonal Antibody Sifalimumab
Oganesyan, Vaheh
Peng, Li
Woods, Robert M.
Wu, Herren
Dall'Acqua, William F.
JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (24) : 14979 - 14985
[9] Macrophage Activation Syndrome (Mas) in Systemic Juvenile Idiopathic Arthritis (Sjia): Treatment with Emapalumab, an Anti-Interferon Gamma (Ifn.) Monoclonal Antibody
De Benedetti, Fabrizio
Grom, Alexei
Brogan, Paul
Bracaglia, Claudia
Pardeo, Manuela
Marucci, Giulia
Eleftheriou, Despina
Papadopoulou, Charalampia
Quartier, Pierre
Anton, Jordi
Frederiksen, Rikke
Asnaghi, Veronica
Ballabio, Maria
de Min, Cristina
PEDIATRIC BLOOD & CANCER, 2022, 69 : S4 - S4
[10] EFFICACY AND SAFETY OF EMAPALUMAB, AN ANTI-INTERFERON GAMMA MONOCLONAL ANTIBODY, IN PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME (MAS) IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) WHO HAD FAILED HIGH-DOSE GLUCOCORTICOIDS
De Benedetti, F.
Grom, A.
Brogan, P.
Bracaglia, C.
Pardeo, M.
Marucci, G.
Eleftheriou, D.
Papadopoulou, C.
Quartier, P.
Anton, J.
Frederiksen, R.
Asnaghi, V.
de Min, C.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 128 - 128

← 1 2 3 4 5 →